41.5 F
New York
Friday, March 29, 2024

FTC Disapproves Anti-Doping and Medication Control Proposed Rule Submitted by the Horseracing Integrity and Safety Authority

The Federal Trade Commission has issued an Order disapproving the Anti-Doping and Medication Control proposed rule submitted by the Horseracing Integrity and Safety Authority to its enforcement rule after a public comment period. The Horseracing Integrity and Safety Act, which recognized the Authority, includes a requirement that its rules must be submitted for approval to the FTC.

The Commission’s Order explains that its disapproval arises from the legal uncertainty arising from a recent decision by the U.S. Court of Appeals for the Fifth Circuit, which declared the Horseracing Integrity and Safety Act unconstitutional. Because the next steps in the litigation could render the proposed rule unenforceable in the states that make up the circuit and in those that are plaintiffs in litigation, approving the proposed rule would be inconsistent with the Act’s foundational principle that horseracing rules be uniform across the nation. Accordingly, the Commission did not reach the merits of the proposed rule, which the Authority may re-submit if the legal uncertainty is resolved.

The Commission vote to approve the rule modification was 3-0-1, with Commissioner Christine S. Wilson abstaining.

Official news published at https://www.ftc.gov/news-events/news/press-releases/2022/12/ftc-disapproves-anti-doping-medication-control-proposed-rule-submitted-horseracing-integrity-safety

Images courtesy of PixaBay

- Part of VUGA Media Group -digital marketing best company

Latest article